Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 18, Number 8—August 2012

CME ACTIVITY

Factors Related to Increasing Prevalence of Resistance to Ciprofloxacin and Other Antimicrobial Drugs in Neisseria gonorrhoeae, United States

Edward GoldsteinComments to Author , Robert D. Kirkcaldy, David Reshef, Stuart Berman, Hillard Weinstock, Pardis Sabeti, Carlos Del Rio, Geraldine Hall, Edward W. Hook, and Marc Lipsitch
Author affiliations: Harvard School of Public Health, Boston, Massachusetts, USA (E. Goldstein, M. Lipsitch); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (R.D. Kirkcaldy, S. Berman, H. Weinstock); Oxford University, Oxford, UK (D. Reshef); Harvard University, Cambridge, Massachusetts, USA (P. Sabeti); Emory University, Atlanta (C. Del Rio); Cleveland Clinic, Cleveland, Ohio, USA (G. Hall); University of Alabama at Birmingham, Birmingham, Alabama, USA (E.W. Hook); and Jefferson County Department of Health, Birmingham (E.W. Hook)

Main Article

Figure 2

Semiannual prevalence of the ciprofloxacin (Cipro)–resistant type of Neisseria gonorrhoeae for men who have sex with men (A) and heterosexual men (B), stratified by resistance characteristics to tetracycline (tet) and penicillin (pen).

Figure 2. . . . . Semiannual prevalence of the ciprofloxacin (Cipro)–resistant type of Neisseria gonorrhoeae for men who have sex with men (A) and heterosexual men (B), stratified by resistance characteristics to tetracycline (tet) and penicillin (pen).

Main Article

TOP